Advanced NSCLC in Focus: Collaborative Management of EGFR Deletion/Mutation and ALK Rearrangement Disease

Danny Nguyen MD, DO; Katherine Cunha, MSN, FNP-C; Michelle Munroe, APRN, and Jun Zhang, MD, PhD discuss how to optimize treatment selection and manage adverse events in advanced non-small cell lung cancer patients with EGFR mutations and ALK rearrangements, emphasizing collaborative care strategies, patient education, and proactive side effect management to maintain treatment adherence and quality of life.